Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ibex Wealth Advisors bought a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the third quarter, HoldingsChannel reports. The firm bought 62,212 shares of the biopharmaceutical company’s stock, valued at approximately $4,662,000. A number of other institutional investors also recently bought and sold shares of the stock. PCA Investment Advisory […]
Savant Capital LLC lessened its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 0.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 26,625 shares of the biopharmaceutical company’s stock after selling 151 shares during the […]
New York State Common Retirement Fund lessened its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,201,505 shares of the biopharmaceutical company’s stock after selling 63,011 shares during […]
Zions Bancorporation N.A. increased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 22.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 48,500 shares of the biopharmaceutical company’s stock after purchasing an additional 9,012 shares during the quarter. […]
Zions Bancorporation N.A. increased its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 22.8% in the third quarter, Holdings Channel reports. The firm owned 48,500 shares of the biopharmaceutical company’s stock after purchasing an additional 9,012 shares during the quarter. Zions Bancorporation N.A.’s holdings in Gilead Sciences were worth $3,635,000 as of its […]